Lansoprazole Market: Global Industry Analysis and Forecast (2022-2027) by Product Type, Application, Route of Administration, and Region

Lansoprazole Market size was valued at US$ 1.70 Bn. in 2021 and the total revenue is expected to grow at a CAGR of 5.8% through 2022 to 2027, reaching nearly US$ 2.38 Bn.

Lansoprazole Market Overview:

Lansoprazole Market is expected to reach US$ 2.38 Bn. by 2027. Lansoprazole is a medication that is used to treat disorders in which the stomach has too much acid. It treats duodenal and stomach ulcers, NSAID-induced gastric ulcers, erosive esophagitis, and gastroesophageal reflux disease (GERD). Capsules, OD Tablet, and Botulinum toxin are the product types of the Lansoprazole. Lansoprazole Market To know about the Research Methodology :- Request Free Sample Report

Lansoprazole Market Dynamics:

Lansoprazole is a proton pump inhibitor that inhibits the production of gastric acid in the stomach, making it easier to treat a variety of gastric illnesses. Proton pump inhibitors function by blocking the proton pump, which is the important region for H+ ion secretion in the stomach lumen. Proton pump inhibitors bind to the proton pump and deactivate it, preventing H+ ions from being secreted into the stomach lumen and thereby decreasing the formation of gastric acid. Lansoprazole is not like other drugs used to treat gastroesophageal reflux disease, such as antacids, which work by neutralizing the acid produced in the stomach. Lansoprazole works on this process to treat GERD, which is characterized by the backward flow of gastric acid from the stomach, causing symptoms like heartburn and acidity. Prescription brands and over-the-counter medications (OTC) in various formats are both available. The rise in the incidence of gastroesophageal reflux disease (GERD), gastric ulcers, duodenal ulcers, and other gastric illnesses is driving the global lansoprazole market. Other factors expected to boost the global lansoprazole market during the forecast period include an increase in demand for proton pump inhibitors and ongoing clinical trials for the evaluation of new lansoprazole formulations targeted at increasing the drug's efficiency. However, new medication classes for the treatment of gastric illnesses, such as H2 blockers, antacids, and others, are expected to hamper the global lansoprazole market during the forecast period, as patients prefer these drug classes that provide fast relief from gastroesophageal reflux disease.

Lansoprazole Market Segment Analysis:

Based on the Route of Administration, the market is segmented into Oral, and Intravenous. Oral route of administration segment is expected to hold the largest market share of xx% by 2027. This is due to patients with mild to moderate gastroesophageal reflux disease preferring capsule formulations, low cost of oral capsules, and an increase in the number of manufacturers in the global market supplying lansoprazole in capsule forms. These are the factors that are expected to drive the growth of the Oral route of administration segment in the Lansoprazole Market during the forecast period. Based on the Product Type, the market is segmented into Capsules, OD Tablet, and Botulinum toxin. Botulinum toxin segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2022-2027. Botulin toxin injections reduce wrinkles by relaxing the muscles that cause them. Migraines, hyperhidrosis, overactive bladder, and eye difficulties are among the medical ailments that can be treated with these injections. Botox is often recommended by doctors for pain relief. Botox relaxes and relieves pain by blocking nerve signals that control muscle action. The neurotoxins utilised in Botox are produced by a bacterium called Clostridium botulinum. For medical injections, healthcare providers utilise a specific type of bacteria (type A). Botulinum toxins are found in soil and contaminated foods in nature. Botulism can be contracted if high doses of botulinum toxins are consumed or if the germs enter a wound. Breathing is affected by this significant nervous system illness. Botox is manufactured in a lab for maximum safety and efficacy. The botulinum toxins are diluted and sterilised so that they do not induce botulism.

Lansoprazole Market Regional Insights:

North American region is expected to dominate the Lansoprazole Market during the forecast period 2022-2027. The North American region is expected to hold the largest market share of xx% by 2027. This is due to an increase in the frequency of GERD in the United States and a larger demand in the region for sustained release proton pump inhibitor medicines. According to the World Gastroenterology Organisation, the prevalence of GERD in Eastern Asia ranged from 2.5 percent to 6.6 percent in 2015, while in North America it ranged from 13.8 percent to 25.8%. These are the factors that are expected to drive the growth of the North American region in the Lansoprazole Market during the forecast period. The objective of the report is to present a comprehensive analysis of the Global Lansoprazole Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also help in understanding the Global Lansoprazole Market dynamic, structure by analyzing the market segments and projecting the Global Lansoprazole Market size. Clear representation of competitive analysis of key players by Technique, price, financial position, product portfolio, growth strategies, and regional presence in the Lansoprazole Market make the report investor’s guide.

Lansoprazole Market Scope: Inquiry Before Buying

Global Lansoprazole Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2027
Historical Data: 2017 to 2021 Market Size in 2021: US $ 1.70 Bn.
Forecast Period 2022 to 2027 CAGR: 5.8% Market Size in 2027: US $ 2.38 Bn.
Segments Covered: by Product Type • Capsules • OD Tablet • Botulinum toxin
by Application • Male • Female
by Application • Oral • Intravenous

Lansoprazole Market, by Region

• North America • Europe • Asia Pacific • South America • Middle East and Africa

Lansoprazole Market Key Players

Takeda Pharmaceutical • Teva Pharms • Sandoz • GSK • Dr. Reddy's • Pfizer • Taj Pharma • Mylan • Cisen Pharmaceutical • Lepu Pharmaceuticals • Nang Kuang Pharmaceutical • Luoxin Biotechnology • Beijing Honglin Pharma • Suzhou YUSHI Pharmaceutical Co. • Changzhou Siyao Pharmaceuticals • Perrigo Company plc • Sun Pharmaceutical Industries Ltd. Frequently Asked Questions: 1] Which region is expected to hold the highest share in the Lansoprazole Market? Ans. North America is expected to hold the highest share in the Lansoprazole Market. 2] Who are the top key players in the Lansoprazole Market? Ans. Takeda Pharmaceutical, Teva Pharms, Sandoz, GSK, Dr. Reddy's, and Pfizer are the top key players in the Lansoprazole Market. 3] Which segment is expected to hold the largest market share in the Lansoprazole Market by 2027? Ans. Oral route of administration segment is expected to hold the largest market share in the Lansoprazole Market by 2027. 4] What is the market size of the Lansoprazole Market by 2027? Ans. The market size of the Lansoprazole Market is expected to reach US $2.38 Bn. by 2027. 5] What was the market size of the Lansoprazole Market in 2021? Ans. The market size of the Lansoprazole Market was worth US $1.70 Bn. in 2021.
1. Global Lansoprazole Market: Research Methodology 2. Global Lansoprazole Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Lansoprazole Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Lansoprazole Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • South America 3.12 COVID-19 Impact 4. Global Lansoprazole Market Segmentation 4.1 Global Lansoprazole Market, by Product Type (2022-2027) • Capsules • OD Tablet • Botulinum toxin 4.2 Global Lansoprazole Market, by Application (2022-2027) • Male • Female 4.3 Global Lansoprazole Market, by Route of Administration (2022-2027) • Oral • Intravenous 5. North America Lansoprazole Market (2022-2027) 5.1 North America Lansoprazole Market, by Product Type (2022-2027) • Capsules • OD Tablet • Botulinum toxin 5.2 North America Lansoprazole Market, by Application (2022-2027) • Male • Female 5.3 North America Lansoprazole Market, by Route of Administration (2022-2027) • Oral • Intravenous 5.4 North America Lansoprazole Market, by Country (2022-2027) • United States • Canada • Mexico 6. Europe Lansoprazole Market (2022-2027) 6.1. Europe Lansoprazole Market, by Product Type (2022-2027) 6.2. Europe Lansoprazole Market, by Application (2022-2027) 6.3. Europe Lansoprazole Market, by Route of Administration (2022-2027) 6.4. Europe Lansoprazole Market, by Country (2022-2027) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Lansoprazole Market (2022-2027) 7.1. Asia Pacific Lansoprazole Market, by Product Type (2022-2027) 7.2. Asia Pacific Lansoprazole Market, by Application (2022-2027) 7.3. Asia Pacific Lansoprazole Market, by Route of Administration (2022-2027) 7.4. Asia Pacific Lansoprazole Market, by Country (2022-2027) • China • India • Japan • South Korea • Australia • ASEAN • Rest of APAC 8. South America Lansoprazole Market (2022-2027) 8.1. South America Lansoprazole Market, by Product Type (2022-2027) 8.2. South America Lansoprazole Market, by Application (2022-2027) 8.3. South America Lansoprazole Market, by Route of Administration (2022-2027) 8.4. South America Lansoprazole Market, by Country (2022-2027) • Brazil • Argentina • Rest of South America 9. Middle East and Africa Lansoprazole Market (2022-2027) 9.1 Middle East and Africa Lansoprazole Market, by Product Type (2022-2027) 9.2. Middle East and Africa Lansoprazole Market, by Application (2022-2027) 9.3. Middle East and Africa Lansoprazole Market, by Route of Administration (2022-2027) 9.4. Middle East and Africa Lansoprazole Market, by Country (2022-2027) • South Africa • GCC • Egypt • Nigeria • Rest of ME&A 10. Company Profile: Key players 10.1 Takeda Pharmaceutical 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2 Teva Pharms 10.3 Sandoz 10.4 GSK 10.5 Dr. Reddy's 10.6 Pfizer 10.7 Taj Pharma 10.8 Mylan 10.9 Cisen Pharmaceutical 10.10 Lepu Pharmaceuticals 10.11 Nang Kuang Pharmaceutical 10.12 Luoxin Biotechnology 10.13 Beijing Honglin Pharma 10.14 Suzhou YUSHI Pharmaceutical Co. 10.15 Changzhou Siyao Pharmaceuticals 10.16 Perrigo Company plc 10.17 Sun Pharmaceutical Industries Ltd.

About This Report

Report ID 74123
Category Material & Chemical
Published Date Oct 2020
Updated Date April 2022
Contact Us